Vetanova (VTNA) Stock Price
Vetanova Price
Vetanova's net margin stands at -3,000.0%, down from -8.9% several years earlier.
Vetanova stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Vetanova over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Vetanova stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Vetanova's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Vetanova Price |
|---|
Vetanova Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Vetanova Income Statement, Balance Sheet, Cash Flow Statement
| EBITM USD |
|---|
| NET INCOMEM USD |
| SHARESM |
| 1999 | 2000 | 2014 | 2015 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -5.00 |
| – | – | – | – | – | – | -19.00 |
| 0.02 | 0.02 | 0.01 | 0.01 | 0.63 | 19.92 | 251.91 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Vetanova generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Vetanova retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Vetanova's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Vetanova has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Vetanova's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Vetanova stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Vetanova Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Vetanova business model & stock analysis
Vetanova SWOT Analysis
Strengths
Vetanova Inc possesses several strengths that contribute to its competitive advantage:
- Strong market presence and brand recognition in the veterinary pharmaceutical industry.
- Diverse range of high-quality and innovative products for animal health and care.
- Established distribution network and partnerships with key retailers and veterinarians.
- Experienced management team with deep industry knowledge and expertise.
Weaknesses
Vetanova Inc also faces certain weaknesses that could hinder its growth and success:
- Relatively small market share compared to larger competitors.
- Dependency on a limited number of suppliers for raw materials.
- Higher production costs due to smaller economies of scale.
- Limited geographic presence and potential difficulties in expanding internationally.
Opportunities
There are several opportunities that Vetanova Inc can capitalize on to strengthen its position:
- Growing demand for pet healthcare products globally, driven by increasing pet ownership.
- Expanding into emerging markets with rising disposable incomes and pet adoption rates.
- Developing partnerships with veterinary clinics to enhance customer reach and product distribution.
- Investing in research and development for new and improved products.
Threats
Vetanova Inc must also be mindful of potential threats that could affect its business:
- Intense competition from large pharmaceutical companies with greater resources and market presence.
- Regulatory challenges and compliance requirements in different jurisdictions.
- Risk of patent infringements and imitation products from competitors.
- Fluctuations in raw material costs and availability.
Vetanova Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Vetanova historical P/E ratio, EBIT multiple, and P/S ratio
Vetanova annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Vetanova shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Vetanova stock splits
Vetanova shareholder structure
| % | Name |
|---|---|
18.86796% | |
11.19310% | |
8.38112% | |
7.84860% | |
4.28258% |
Vetanova Executives and Management Board
Mr. Paul Gorman
(50)Chief Executive Officer, Director · since 2006
Mr. Howard Barth
(65)Director · since 2005
Mr. Rakesh Malhotra
(61)Chief Financial Officer · since 2005
Kenneth Hill
(73)Director · since 2006
Lisa Rose
(39)Corporate Secretary · since 2005
Frequently asked questions about Vetanova
The business model of Vetanova Inc is focused on developing and commercializing innovative veterinary pharmaceutical products. They specialize in producing medications that improve the health and well-being of animals, addressing various veterinary conditions and providing effective treatment options. Vetanova Inc strives to contribute to the advancement of veterinary medicine by leveraging its research and development capabilities, as well as its expertise in formulation and production. The company aims to provide high-quality solutions that meet the specific needs of pets and livestock, serving as a reliable partner in animal healthcare.
Vetanova stock
Vetanova Peer Group
Vetanova FIGI
All fundamentals and in-depth analysis of Vetanova
Our stock analysis for Vetanova stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vetanova. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.